Literature DB >> 26720730

A Comparative Effectiveness Trial of Alternate Formats for Presenting Benefits and Harms Information for Low-Value Screening Services: A Randomized Clinical Trial.

Stacey L Sheridan1, Anne Sutkowi-Hemstreet2, Colleen Barclay3, Noel T Brewer4, Rowena J Dolor5, Ziya Gizlice6, Carmen L Lewis7, Daniel S Reuland1, Carol E Golin1, Christine E Kistler8, Maihan Vu4, Russell Harris1.   

Abstract

IMPORTANCE: Healthcare overuse, the delivery of low-value services, is increasingly recognized as a critical problem. However, little is known about the comparative effectiveness of alternate formats for presenting benefits and harms information to patients as a strategy to reduce overuse.
OBJECTIVE: To examine the effect of different benefits and harms presentations on patients' intentions to accept low-value or potentially low-value screening services (prostate cancer screening in men ages 50-69 years; osteoporosis screening in low-risk women ages 50-64 years; or colorectal cancer screening in men and women ages 76-85 years). DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of 775 individuals eligible to receive information about any 1 of the 3 screening services and scheduled for a visit with their clinician. Participants were randomized to 1 of 4 intervention arms that differed in terms of presentation format: words, numbers, numbers plus narrative, and numbers plus framed presentation. The trial was conducted from September 2012 to June 2014 at 2 family medicine and 2 internal medicine practices affiliated with the Duke Primary Care Research Consortium. The data were analyzed between May and September of 2015.
INTERVENTIONS: One-page evidence-based decision support sheets on each of the 3 screening services, with benefits and harms information presented in 1 of 4 formats: words, numbers, numbers plus narratives, or numbers plus a framed presentation. MAIN OUTCOMES AND MEASURES: The primary outcome was change in intention to accept screening (on a response scale from 1 to 5). Our secondary outcomes included general and disease-specific knowledge, perceived risk and consequences of disease, screening attitudes, perceived net benefit of screening, values clarity, and self-efficacy for screening.
RESULTS: We enrolled and randomly allocated 775 individuals, aged 50 to 85 years, to 1 of 4 intervention arms: 195 to words, 192 to numbers, 196 to narrative, and 192 to framed formats. Intentions to accept screening were high before the intervention and change in intentions did not differ across intervention arms (words, -0.07; numbers, -0.05; numbers plus narrative, -0.12; numbers plus framed presentation, -0.02; P = .57 for all comparisons). Change in other outcomes also showed no difference across intervention arms. Results were similar when stratified by screening service. CONCLUSIONS AND RELEVANCE: Single, brief, written decision support interventions, such as the ones in this study, are unlikely to be sufficient to change intentions for screening. Alternate and additional interventions are needed to reduce overused screening services. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01694784.

Entities:  

Mesh:

Year:  2016        PMID: 26720730     DOI: 10.1001/jamainternmed.2015.7339

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  12 in total

1.  Patient Decision Aids for Discouraging Low-Value Health Care Procedures: Null Findings and Lessons Learned.

Authors:  Judith J Prochaska; Ashley Sanders-Jackson
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

2.  Persuasive Interventions for Controversial Cancer Screening Recommendations: Testing a Novel Approach to Help Patients Make Evidence-Based Decisions.

Authors:  Barry G Saver; Kathleen M Mazor; Roger Luckmann; Sarah L Cutrona; Marcela Hayes; Tatyana Gorodetsky; Nancy Esparza; Gonzalo Bacigalupe
Journal:  Ann Fam Med       Date:  2017-01-06       Impact factor: 5.166

3.  Understandability of Patient Information Booklets for Patients with Cancer.

Authors:  Christian Keinki; Richard Zowalla; Martin Wiesner; Marie Jolin Koester; Jutta Huebner
Journal:  J Cancer Educ       Date:  2018-06       Impact factor: 2.037

4.  A prototype for evidence-based pharmaceutical opinions to promote physician-pharmacist communication around deprescribing.

Authors:  Philippe Martin; Cara Tannenbaum
Journal:  Can Pharm J (Ott)       Date:  2018-02-08

5.  Avoiding fears and promoting shared decision-making: How should physicians inform patients about radiation exposure from imaging tests?

Authors:  Blanca Lumbreras; José Vilar; Isabel González-Álvarez; Mercedes Guilabert; María Pastor-Valero; Lucy Anne Parker; Jorge Vilar-Palop; Ildefonso Hernández-Aguado
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

6.  Exploring factors that might influence primary-care provider discussion of and recommendation for prostate and colon cancer screening.

Authors:  Christine E Kistler; Maihan Vu; Anne Sutkowi-Hemstreet; Ziya Gizlice; Russell P Harris; Noel T Brewer; Carmen L Lewis; Rowena J Dolor; Colleen Barclay; Stacey L Sheridan
Journal:  Int J Gen Med       Date:  2018-05-17

Review 7.  A Review of the Presentation of Overdiagnosis in Cancer Screening Patient Decision Aids.

Authors:  Ashley J Housten; Lisa M Lowenstein; Aubri Hoffman; Lianne E Jacobs; Zineb Zirari; Diana S Hoover; Dawn Stacey; Greg Pratt; Therese B Bevers; Robert J Volk
Journal:  MDM Policy Pract       Date:  2019-11-06

8.  A survey of primary care patients' readiness to engage in the de-adoption practices recommended by Choosing Wisely Canada.

Authors:  William Silverstein; Elliot Lass; Karen Born; Anne Morinville; Wendy Levinson; Cara Tannenbaum
Journal:  BMC Res Notes       Date:  2016-06-10

9.  Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review.

Authors:  Robin W M Vernooij; Lyubov Lytvyn; Hector Pardo-Hernandez; Loai Albarqouni; Carlos Canelo-Aybar; Karen Campbell; Thomas Agoritsas
Journal:  BMJ Open       Date:  2018-09-05       Impact factor: 2.692

10.  Patient Attitudes Toward Individualized Recommendations to Stop Low-Value Colorectal Cancer Screening.

Authors:  Marc S Piper; Jennifer K Maratt; Brian J Zikmund-Fisher; Carmen Lewis; Jane Forman; Sandeep Vijan; Valbona Metko; Sameer D Saini
Journal:  JAMA Netw Open       Date:  2018-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.